Oxidative stress and ferritin levels in haemodialysis patients
dc.contributor.buuauthor | Şenol, Emel | |
dc.contributor.buuauthor | Ersoy, Alpaslan | |
dc.contributor.buuauthor | Sarandol, Emre | |
dc.contributor.buuauthor | Yurtkuran, Mustafa | |
dc.contributor.buuauthor | Erdinç, Selda | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-2593-7196 | tr_TR |
dc.contributor.orcid | 0000-0002-0710-0923 | tr_TR |
dc.contributor.researcherid | ABE-1716-2020 | tr_TR |
dc.contributor.researcherid | ABE-1716-2020 | tr_TR |
dc.contributor.scopusid | 24336329900 | tr_TR |
dc.contributor.scopusid | 35612977100 | tr_TR |
dc.contributor.scopusid | 24334883200 | tr_TR |
dc.contributor.scopusid | 55943324800 | tr_TR |
dc.contributor.scopusid | 7003389525 | tr_TR |
dc.date.accessioned | 2021-12-14T07:49:55Z | |
dc.date.available | 2021-12-14T07:49:55Z | |
dc.date.issued | 2008-02 | |
dc.description.abstract | Background. Increased oxidative stress (OS) and inflammation are associated with atherosclerotic coronary artery disease in haemodialysis (HD) patients. Ferritin may have other effects in addition to its role in storing intracellular iron. This study was performed to determine any relationships between markers of OS, nutrition and inflammation in HD patients with normal and high ferritin levels. Methods. Our cohort comprised 34 maintenance dialysis patients on erythropoietin therapy and 22 healthy controls. HD patients were divided into two groups: 17 with normal (<800 ng/ml) and 17 with high (>800 ng/ml) ferritin levels, and we measured lipid profile, albumin, highly sensitive C-reactive protein (hsCRP), anti-oxidant enzymes [whole blood glutathione peroxidase (Gpx), serum superoxide dismutase (SOD), paraoxonase, arylestherase (AE) and total anti-oxidant status (TAOC)], anti-oxidants (vitamin C) and lipid peroxidation products [red blood cell malondialdehyde (RBC MDA)]. Results. Compared with controls, the HD patients had higher serum urea, blood pressure, triglyceride, hsCRP, RBC MDA, SOD and TAOC values and lower albumin, low-density lipoprotein cholesterol, apolipoprotein AI, paraoxonase, AE and whole blood Gpx activities. Serum vitamin C, uric acid, apolipoprotein B, total- and high-density lipoprotein cholesterol, apolipoprotein B MDA, and lymphocyte levels in the HD patients with normal and high ferritin levels were similar. The OS markers of HD patients did not differ, whether or not they received intravenous iron supplementation or had transferrin saturations <50 or >= 50. Conclusion. HD patients are in a higher oxidative state, which results in the reduction of total anti-oxidant capacity and also have an increased inflammation status. We could not find a relationship between ferritin level and OS markers in HD patients receiving erythropoietin. | en_US |
dc.identifier.citation | Şenol, E. vd. (2008). ''Oxidative stress and ferritin levels in haemodialysis patients''. Nephrology Dialysis Transplantation, 23(2), 665-672. | en_US |
dc.identifier.endpage | 672 | tr_TR |
dc.identifier.issn | 0931-0509 | |
dc.identifier.issue | 2 | tr_TR |
dc.identifier.pubmed | 18039638 | tr_TR |
dc.identifier.scopus | 2-s2.0-44449126216 | tr_TR |
dc.identifier.startpage | 665 | tr_TR |
dc.identifier.uri | https://doi.org/10.1093/ndt/gfm588 | |
dc.identifier.uri | https://academic.oup.com/ndt/article/23/2/665/1851197 | |
dc.identifier.uri | http://hdl.handle.net/11452/23234 | |
dc.identifier.volume | 23 | tr_TR |
dc.identifier.wos | 000253022300037 | tr_TR |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Oxford Univ Press | en_US |
dc.relation.bap | T-2006/14 | tr_TR |
dc.relation.journal | Nephrology Dialysis Transplantation | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Erythropoietin | en_US |
dc.subject | Ferritin | en_US |
dc.subject | Haemodialysis | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Nutrition | en_US |
dc.subject | Oxidative stress | en_US |
dc.subject | Chronic kidney-disease | en_US |
dc.subject | Stage renal-disease | en_US |
dc.subject | Serum paraoxonase | en_US |
dc.subject | Oxidant stress | en_US |
dc.subject | Lipid-peroxidation | en_US |
dc.subject | Iron therapy | en_US |
dc.subject | Protein | en_US |
dc.subject | Atherosclerosis | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Transplantation | en_US |
dc.subject | Urology & nephrology | en_US |
dc.subject | Plasma | en_US |
dc.subject.emtree | Albumin | en_US |
dc.subject.emtree | Angiotensin receptor antagonist | en_US |
dc.subject.emtree | Apolipoprotein B | en_US |
dc.subject.emtree | Aryldialkylphosphatase | en_US |
dc.subject.emtree | Arylesterase | en_US |
dc.subject.emtree | Ascorbic acid | en_US |
dc.subject.emtree | Beta adrenergic receptor blocking agent | en_US |
dc.subject.emtree | C reactive protein | en_US |
dc.subject.emtree | Calcidiol 1 monooxygenase | en_US |
dc.subject.emtree | Calcitriol | en_US |
dc.subject.emtree | Calcium channel blocking agent | en_US |
dc.subject.emtree | Dipeptidyl carboxypeptidase inhibitor | en_US |
dc.subject.emtree | Ferritin | en_US |
dc.subject.emtree | Glutathione peroxidase | en_US |
dc.subject.emtree | High density lipoprotein | en_US |
dc.subject.emtree | Iron | en_US |
dc.subject.emtree | Low density lipoprotein | en_US |
dc.subject.emtree | Malonaldehyde | en_US |
dc.subject.emtree | Recombinant erythropoietin | en_US |
dc.subject.emtree | Superoxide dismutase | en_US |
dc.subject.emtree | Triacylglycerol | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Atherosclerosis | en_US |
dc.subject.emtree | Cholesterol blood level | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Enzyme activity | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Ferritin blood level | en_US |
dc.subject.emtree | Hemodialysis | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hypertension | en_US |
dc.subject.emtree | Iron deficiency | en_US |
dc.subject.emtree | Lipid peroxidation | en_US |
dc.subject.emtree | Lymphocyte count | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Nutrition | en_US |
dc.subject.emtree | Oxidative stress | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Uremia | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Erythropoietin | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Ferritins | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Oxidative stress | en_US |
dc.subject.mesh | Renal dialysis | en_US |
dc.subject.scopus | Hemodialysis; Ascorbic Acid Deficiency; Chronic Kidney Failure | en_US |
dc.subject.wos | Transplantation | en_US |
dc.subject.wos | Urology & nephrology | en_US |
dc.title | Oxidative stress and ferritin levels in haemodialysis patients | en_US |
dc.type | Article | |
dc.wos.quartile | Q1 (Urology & nephrology) | en_US |
dc.wos.quartile | Q2 (Transplantation) | en_US |